Closed-loop Response to Unannounced Mixed and Carbohydrates-rich Breakfasts
CRUMB
The CRUMB Study: Closed-loop Response to Unannounced Mixed and Carbohydrates-rich Breakfasts. A Randomized Controlled Crossover Pilot-study in a Cohort of Adolescents With Type 1 Diabetes.
1 other identifier
interventional
20
1 country
1
Brief Summary
The development of advanced hybrid closed-loop (a-HCL) systems represents a significant step toward in improving glucose control and reducing user-dependent variability, especially In pediatric patients. Systems can automatically deliver correction boluses and modulate insulin delivery based on CGM feedback, thereby compensating for some of the consequences of human error. Current evidence suggests that a-HCL systems can tolerate unannounced carbohydrate loads up to approximately 20 g without compromising time in range (TIR) or safety. However, the metabolic response to larger or compositionally complex meals remains variable and highly dependent on the specific algorithm governing insulin delivery. Currently a variety of AID are commercially available: all of them present similarities and differences. The Medtronic MiniMed™ 780G uses a proportional-integral-derivative (PID) algorithm, a mathematical model that adjusts in real time insulin delivery rate based on 3 elements obtained from CGM reading values: the difference between the actual value and the chosen glucose target (proportional action), past values (integral action) and the glucose's rate of change (derivative action), In contrast, the Tandem t:slim X2™ with Control-IQ employs a model predictive control (MPC) algorithm, which aims, through a complex mathematical model, to predict glucose trends up to half-an-hour in the future, takin, also, in consideration actual and past glucose values. Despite sharing the same objective, said algorithms have different approaches, the former one being "reactive" and the latter "predictive". Therefore, their difference could result in different performances while facing mixed-nutrient meal or unannounced meals, defined as the consumptions of a meal with any prior insulin administration. Pediatric patients represent certainly a unique subgroup in which therapeutic adherence is a relevant issue, due to cognitive, developmental and behavioral factors. Understanding how different AID algorithms respond to unannounced meals in this age group is therefore crucial for optimizing safety and personalization of diabetes management. This study was designed to evaluate the strengths and limitations of two a-HCL systems, the Medtronic 780G (PID algorithm) and the Tandem t:slim X2 (MPC algorithm), in managing unannounced meals with different macronutrient compositions in children and adolescents with T1D. We also aim to better understand physiological and technological unannounced meal implications as to provide additional insight useful for the development of new fully closed loop algorithms, capable of minimizing glucose excursions and patient's burden.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 20, 2025
CompletedFirst Submitted
Initial submission to the registry
February 23, 2026
CompletedFirst Posted
Study publicly available on registry
March 6, 2026
CompletedMarch 6, 2026
March 1, 2026
1 month
February 23, 2026
March 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in blood glucose concentration from pre-meal to two hours post-meal (2h-ΔBG), as measured by CGM in mg/dl
Change in blood glucose concentration from pre-meal to two hours post-meal (2h-ΔBG), as measured by CGM
from pre-meal to two hours post-meal
Secondary Outcomes (8)
Pre- and post-meal four-hour glucose difference (4h-ΔBG), as measured by CGM in mg/dl
from pre-meal to four hour postprandial
Peak CGM value in mg/dl
from pre-meal to four hour postprandial
Time to peak CGM value
from pre-meal to four hour postprandial
Percentage of spent time in range (TIR, 70-180 mg/dL), as measured by CGM
from pre-meal to four hour postprandial
Percentage of spent time in tight range (TITR, 70-140 mg/dL), as measured by CGM
from pre-meal to four hour postprandial
- +3 more secondary outcomes
Study Arms (2)
Announced meal (AM)
NO INTERVENTIONParticipants followed their usual therapy while consuming both the "CHO meal" and the "mixed meal" three times each. In this phase, the carbohydrate content of each meal was announced to the insulin pump, and pre-meal boluses were delivered as per standard practice.
Unannounced meal (UM)
EXPERIMENTALParticipants consumed the same meals, an equal number of times, without announcing their carbohydrate intake to the device. Consequently, no user-initiated boluses were administered during this period, and all insulin delivery adjustments were determined exclusively by the algorithm.
Interventions
Participants consumed both the "CHO meal" and the "mixed meal" three times each, without announcing their carbohydrate intake to the device. Consequently, no user-initiated boluses were administered during this period, and all insulin delivery adjustments were determined exclusively by the algorithm.
Eligibility Criteria
You may qualify if:
- Age between 11 and 18 years;
- Type 1 diabetes diagnosed for at least 12 months;
- Use of an A-HCL device for at least 3 months;
- Proficiency in carbohydrate counting.
You may not qualify if:
- Presence of malabsorption disorders;
- Presence of chronic diabetes complications.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco" - Catania
Catania, Sicily, 95123, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 23, 2026
First Posted
March 6, 2026
Study Start
April 20, 2025
Primary Completion
May 20, 2025
Study Completion
May 20, 2025
Last Updated
March 6, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share